← FDA Drug Approvals (Drugs@FDA)

C-SOLVE-2

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: FOUGERA PHARMS · Approved 1985-07-03

Drug application

FDA Application #

ANDA062468

Application type

Abbreviated New Drug Application (Generic)

Brand name

C-SOLVE-2

Generic name

Erythromycin

Active ingredients

ERYTHROMYCIN

Dosage form

SOLUTION

Route

TOPICAL

Marketing status

Discontinued

Sponsor

FOUGERA PHARMS

First approval

1985-07-03

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown